Statistics

Total Visits

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.44

Select a period of time:

Number of views in the range

Views
Open label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors: The Greko II study-GETHI 2013-01.25

Views

Views
October 20242
November 20241
December 20241
January 20252
February 20254
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore13
United States12
 

Top cities views

Views